CHRONIC KIDNEY DISEASE IN CHILDREN STUDY (CKID)

儿童慢性肾病研究 (CKID)

基本信息

  • 批准号:
    7951151
  • 负责人:
  • 金额:
    $ 0.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Chronic Kidney Disease in Children (CKiD) study is a prospective cohort enrolling 540 children between January 2005 and December 2006, which is sponsored by the US National Institutes of Health (i.e., NIDDK, NINDA, NICHD and NLHBI). Eligible children are aged 1 to 16 years with an estimated glomerular filtration rate (GFR) between 30 and 75 ml/min|1.73m2 via the Schwartz formula at study entry; CKiD will exclude children who have had organ or stem cell transplantation; cancer/leukemia treatment, HIV treatment, or pregnancy within the past year; dialysis within the past 3 months; or a previous diagnosis of structural heart disease or a genetic syndrome involving the central nervous system (e.g., Downs syndrome). Annual study visits consist of physician examination, collection of blood and urine samples, and questionnaires eliciting information on quality of life, demographics, and medical and family histories. At alternating annual study visits, children further undertake (a) GFR estimated by Iohexol plasma disappearance curves, echocardiogram, and 24-hour ambulatory blood pressure monitoring, or (b) neurocognitive screening and additional biological specimens to quantify growth. Primary goals are to determine (1) the risk factors for decline in renal function; (2) the incidence of, and risk factors for, impaired neurocognitive development; (3) the prevalence of risk factors for cardiovascular disease; and (4) the long-term effects of growth failure and its treatment. The primary outcome is the rate of decline in GFR; a secondary outcome is time-to-ESRD, defined by transplantation, dialysis, or a 50% decline in GFR. With a two-sided type I error rate of 5%, CKiD is designed to have 80% statistical power to detect a 1.25-fold ratio of the slope of GFR in 208 exposed children to 312 unexposed children, allowing for attrition of 10%, 5% and 5% over the first 3 years of follow up, a dependence among the repeated measurements of GFR within children, and an overall annual decline in GFR of 5 ml/min|1.73m2 (study website: www.statepi.jhsph.edu).
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN MENDLEY其他文献

SUSAN MENDLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN MENDLEY', 18)}}的其他基金

IMPACT OF WT REDUCTION INTERVENTION ON BP & CV RISK FACTORS IN OBESE CHILDREN
WT 减少干预措施对血压的影响
  • 批准号:
    7951177
  • 财政年份:
    2009
  • 资助金额:
    $ 0.26万
  • 项目类别:
IMPACT OF WT REDUCTION INTERVENTION ON BP & CV RISK FACTORS IN OBESE CHILDREN
WT 减少干预措施对血压的影响
  • 批准号:
    7718096
  • 财政年份:
    2008
  • 资助金额:
    $ 0.26万
  • 项目类别:
CHRONIC KIDNEY DISEASE IN CHILDREN STUDY (CKID)
儿童慢性肾病研究 (CKID)
  • 批准号:
    7608150
  • 财政年份:
    2007
  • 资助金额:
    $ 0.26万
  • 项目类别:
CHRONIC KIDNEY DISEASE IN CHILDREN STUDY (CKID)
儿童慢性肾病研究 (CKID)
  • 批准号:
    7376969
  • 财政年份:
    2006
  • 资助金额:
    $ 0.26万
  • 项目类别:
PERITONEAL DIALYSIS ADEQUACY IN CHILDREN
儿童腹膜透析的充分性
  • 批准号:
    6275278
  • 财政年份:
    1997
  • 资助金额:
    $ 0.26万
  • 项目类别:
PERITONEAL DIALYSIS ADEQUACY IN CHILDREN
儿童腹膜透析的充分性
  • 批准号:
    6245147
  • 财政年份:
    1997
  • 资助金额:
    $ 0.26万
  • 项目类别:
MATHEMATICAL MODELING OF HEMODIALYSIS AND MEASUREMENT OF BODY WATER
血液透析和体内水分测量的数学模型
  • 批准号:
    6245185
  • 财政年份:
    1997
  • 资助金额:
    $ 0.26万
  • 项目类别:
PERITONEAL DIALYSIS ADEQUACY IN CHILDREN
儿童腹膜透析的充分性
  • 批准号:
    3740047
  • 财政年份:
  • 资助金额:
    $ 0.26万
  • 项目类别:
PERITONEAL DIALYSIS ADEQUACY IN CHILDREN
儿童腹膜透析的充分性
  • 批准号:
    5218054
  • 财政年份:
  • 资助金额:
    $ 0.26万
  • 项目类别:
PERITONEAL DIALYSIS ADEQUACY IN CHILDREN
儿童腹膜透析的充分性
  • 批准号:
    6114043
  • 财政年份:
  • 资助金额:
    $ 0.26万
  • 项目类别:

相似海外基金

investigation of novel biomarkers for depression by multi-omics analysis of the human biological hippocampus and blood samples
通过对人类生物海马体和血液样本进行多组学分析来研究抑郁症的新型生物标志物
  • 批准号:
    23K14804
  • 财政年份:
    2023
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
  • 批准号:
    22K21006
  • 财政年份:
    2022
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Establishment of blood-based biomarkers to reflect age-related changes in biological membrane
建立基于血液的生物标志物以反映生物膜与年龄相关的变化
  • 批准号:
    22K19762
  • 财政年份:
    2022
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Biological effects of bisphosphonates on bone-specific blood vessels and perivascular cells
双膦酸盐对骨特异性血管和血管周围细胞的生物学效应
  • 批准号:
    22K17000
  • 财政年份:
    2022
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
  • 批准号:
    21K18268
  • 财政年份:
    2021
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Biological action of PTH/PTHrP on bone-specific blood vessels and osteo-vascular interaction
PTH/PTHrP 对骨特异性血管和骨血管相互作用的生物学作用
  • 批准号:
    21H03103
  • 财政年份:
    2021
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular biological analysis on peripheral blood and pharyngeal mucosa of Kawasaki disease children
川崎病患儿外周血及咽黏膜的分子生物学分析
  • 批准号:
    16K10042
  • 财政年份:
    2016
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
HHSN2612012000151/HHSN2610006Base Contract Title: Preclinical Efficacy and Intermediate Biomarkers. Task Order Title: Modulation of miRNA Expression in Blood or Other Biological Fluids Compared wi
HHSN2612012000151/HHSN2610006基本合同标题:临床前功效和中间生物标志物。
  • 批准号:
    8947461
  • 财政年份:
    2014
  • 资助金额:
    $ 0.26万
  • 项目类别:
Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi
现成的全生物小直径血管的开发
  • 批准号:
    8497217
  • 财政年份:
    2013
  • 资助金额:
    $ 0.26万
  • 项目类别:
Establishment of the mesureing system for early diagnosis of Alzheimer's disease using blood biological markers.
建立利用血液生物标志物早期诊断阿尔茨海默病的测量系统。
  • 批准号:
    23790990
  • 财政年份:
    2011
  • 资助金额:
    $ 0.26万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了